Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H22N2O6S2 |
Molecular Weight | 414.496 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C2=CC=C(OCC#CCO)C=C2
InChI
InChIKey=MAVDNGWEBZTACC-HNNXBMFYSA-N
InChI=1S/C17H22N2O6S2/c1-17(2)15(16(21)18-22)19(9-12-26-17)27(23,24)14-7-5-13(6-8-14)25-11-4-3-10-20/h5-8,15,20,22H,9-12H2,1-2H3,(H,18,21)/t15-/m0/s1
Molecular Formula | C17H22N2O6S2 |
Molecular Weight | 414.496 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14718605
Curator's Comment: # Wyeth Research
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P78536 Gene ID: 6868.0 Gene Symbol: ADAM17 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/14718605 |
|||
Target ID: P45452 Gene ID: 4322.0 Gene Symbol: MMP13 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/14718605 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis. | 2004 Apr |
|
Drug evaluation: apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis. | 2006 Nov |
|
A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells. | 2010 Jan 1 |
|
Pharmacokinetic-pharmacodynamic modeling of apratastat: a population-based approach. | 2011 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00095342
Unknown
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21059888
Apratastat inhibited TNF-α release with a population mean IC(50) of 144 ng/mL in vitro
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:11:18 UTC 2023
by
admin
on
Fri Dec 15 16:11:18 UTC 2023
|
Record UNII |
C6BZ5263BJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1970
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL206815
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
QQ-22
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
DTXSID10870312
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
C76767
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
300000034147
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
C6BZ5263BJ
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
287405-51-0
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
8578
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
DB13020
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY | |||
|
11452716
Created by
admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|